NCT06332638View on ClinicalTrials.gov

PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Healthy
Interventions
DRUG

Tegoprazan 12.5mg

Oral administration of one tablet of Tegoprazan 12.5mg twice daily for 14 days.

DRUG

Tegoprazan 25mg

Oral administration of one tablet of Tegoprazan 25mg once daily for 14 days.

DRUG

Famotidine 20mg

Oral administration of one tablet of Famotidine 20mg twice daily for 14 days.

Trial Locations (1)

47392

Inje University Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY